Takeda-backed Ascentage Pharma aims to raise $126 million in US IPO
Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.
Hosted on MSN56m
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing
Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...
Venture Global LNG raises $1.75 billion after pricing US IPO
Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering, the second-largest exporter of liquefied natural gas in the United States said on Thursday.
Birthright citizenship order: ’Terrified’ Indian parents line-up for urgent C-sections as Trump’s Feb 19 deadline nears
The new birthright citizenship order is expected to impact thousands of Indian parents as many hold H-1B and L1 visas. Some ...